MedPath

Chartwell Rx, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

231

FDA:231

Drug Approvals

IRBESARTAN

Approval Date
May 7, 2025
FDA

Repaglinide

Approval Date
May 2, 2025
FDA

Dapsone

Approval Date
Apr 29, 2025
FDA

BUPROPION HYDROCHLORIDE (XL)

Approval Date
Apr 5, 2024
FDA

Lactulose

Approval Date
Apr 5, 2024
FDA

Oxcarbazepine

Approval Date
Apr 4, 2024
FDA

Ciclopirox

Approval Date
Apr 4, 2024
FDA

Amoxicillin

Approval Date
Apr 3, 2024
FDA

Risperidone

Approval Date
Apr 2, 2024
FDA

Doxycycline Hyclate

Approval Date
Apr 1, 2024
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 24
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.